The JPM Effect In Short Supply But BioAge And Bayer Gain

 
• By Andrew McConaghie
  
The mood at this year's J.P. Morgan conference in San Francisco was more upbeat despite few positive deals or other catalysts emerging. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business